RPC Stock Analysis: Ridgepost Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 944m USD | 12M Return: -28.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.09M
EPS Trend: 82.4%
Qual. Beats: 2
Rev. Trend: 94.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ridgepost Capital, Inc. (NYSE: RPC) is a multi-asset class private market solutions provider operating in the alternative asset management industry across the United States, North America, Europe, and other international markets. The firm offers a diversified suite of private market solutions, including private equity, venture capital, impact investing, and private credit, along with primary fund of funds, secondary investment, and direct and co-investment services. The company distributes its offerings through a multi-brand platform: private equity solutions under the RCP Advisors, Bonaccord Capital, Ridgepost Advisors, and Qualitas brands; venture capital under the TrueBridge brand; impact investing under the Enhanced brand; and private credit under the Five Points, Hark Capital, and WTI brands.
The company was founded in 1992 and is headquartered in Dallas, Texas. It was previously known as P10, Inc. and adopted the Ridgepost Capital name in February 2026. As a player in the alternative asset management sector, Ridgepost Capital generates revenue primarily through management fees and performance-based incentives (commonly known as carried interest) on assets managed across its various private market strategies. The multi-brand, multi-strategy structure is a common approach in alternative asset management, allowing each subsidiary to maintain specialized expertise and brand identity while benefiting from shared corporate infrastructure.
- Private credit AUM expands as institutional demand for yield accelerates
- Fundraising momentum and new fund vintages grow fee-earning AUM
- Exit activity and realizations drive performance fee revenue
| Net Income: 23.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -4.57 > 1.0 |
| NWC/Revenue: 47.59% < 20% (prev 31.06%; Δ 16.53% < -1%) |
| CFO/TA 0.05 > 3% & CFO 44.8m > Net Income 23.5m |
| Net Debt (403.2m) to EBITDA (103.8m): 3.88 < 3 |
| Current Ratio: 9.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (117.3m) vs 12m ago -1.72% < -2% |
| Gross Margin: 63.09% > 18% (prev 47.89%; Δ 15.20% > 0.5%) |
| Asset Turnover: 34.10% > 50% (prev 33.97%; Δ 0.13% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBIT TTM 77.9m / Interest Expense TTM 27.3m) |
| A: 0.16 (Total Current Assets 161.4m - Total Current Liabilities 16.4m) / Total Assets 909.7m |
| B: -0.20 (Retained Earnings -186.3m / Total Assets 909.7m) |
| C: 0.09 (EBIT TTM 77.9m / Avg Total Assets 893.5m) |
| D: 0.69 (Book Value of Equity 351.2m / Total Liabilities 506.4m) |
| Altman-Z'' = 1.69 = BB |
| DSRI: 1.10 (Receivables 131.5m/116.7m, Revenue 304.7m/298.0m) |
| GMI: 0.76 (GM 47.89% / 63.09%) |
| AQI: 1.05 (AQ_t 0.79 / AQ_t-1 0.75) |
| SGI: 1.02 (Revenue 304.7m / 298.0m) |
| TATA: -0.02 (NI 23.5m - CFO 44.8m) / TA 909.7m) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of July 28, 2026, the stock is trading at USD 8.70 with a total of 301,566 shares traded. Over the past week, the price has changed by +1.40%, over one month by +14.47%, over three months by +12.80% and over the past year by -28.84%.
Current recommended Stop Loss: 7.80 (which is 10.3% or 2.6 ATR below the current price).
Ridgepost Capital has no consensus analysts rating.
P/E Trailing = 40.8571
P/E Forward = 8.2645
P/S = 3.099
P/B = 2.7448
Revenue TTM = 304.7m USD
EBIT TTM = 77.9m USD
EBITDA TTM = 103.8m USD
Long Term Debt = 315.7m USD (from longTermDebt, last quarter)
Short Term Debt = 16.4m USD (from shortTermDebt, last quarter)
Debt = 433.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 29.1m
Net Debt = 403.2m USD (calculated: Debt 433.1m - CCE 29.9m)
Enterprise Value = 1.35b USD (944.3m + Debt 433.1m - CCE 29.9m)
Interest Coverage Ratio = 2.85 (Ebit TTM 77.9m / Interest Expense TTM 27.3m)
EV/FCF = 33.09x (Enterprise Value 1.35b / FCF TTM 40.7m)
FCF Yield = 3.02% (FCF TTM 40.7m / Enterprise Value 1.35b)
FCF Margin = 13.36% (FCF TTM 40.7m / Revenue TTM 304.7m)
Net Margin = 7.70% (Net Income TTM 23.5m / Revenue TTM 304.7m)
Gross Margin = 63.09% ((Revenue TTM 304.7m - Cost of Revenue TTM 112.5m) / Revenue TTM)
Gross Margin QoQ = 92.13% (prev 60.41%)
Tobins Q-Ratio = 1.48 (Enterprise Value 1.35b / Total Assets 909.7m)
Interest Expense / Debt = 6.31% (Interest Expense 27.3m / Debt 433.1m)
Taxrate = 32.08% (13.2m / 41.2m)
NOPAT = 52.9m (EBIT 77.9m * (1 - 32.08%))
Current Ratio = 9.85 (Total Current Assets 161.4m / Total Current Liabilities 16.4m)
Debt / Equity = 1.23 (Debt 433.1m / totalStockholderEquity, last quarter 351.2m)
Debt / EBITDA = 3.88 (Net Debt 403.2m / EBITDA 103.8m)
Debt / FCF = 9.90 (Net Debt 403.2m / FCF TTM 40.7m)
Total Stockholder Equity = 346.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.63% (Net Income 23.5m / Total Assets 909.7m)
RoE = 6.78% (Net Income TTM 23.5m / Total Stockholder Equity 346.3m)
RoCE = 11.77% (EBIT 77.9m / Capital Employed (Equity 346.3m + L.T.Debt 315.7m))
RoIC = 5.92% (NOPAT 52.9m / Invested Capital 894.5m)
WACC = 8.65% (E(944.3m)/V(1.38b) * Re(10.65%) + D(433.1m)/V(1.38b) * Rd(6.31%) * (1-Tc(0.32)))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.27 | Cagr: 0.38%
[DCF] Terminal Value 71.98% ; FCFF base≈56.2m ; Y1≈49.3m ; Y5≈39.8m
[DCF] Fair Price = 2.61 (EV 609.0m - Net Debt 403.2m = Equity 205.8m / Shares 78.8m; r=8.65% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 82.37 | EPS CAGR: 21.38% | SUE: 0.94 | # QB: 2
Revenue Correlation: 94.84 | Revenue CAGR: 12.09% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.22 | Chg30d=-3.38% | Revisions=-25% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.28 | Chg30d=-0.14% | Revisions=-25% | Analysts=3
EPS current Year (2026-12-31): EPS=1.02 | Chg30d=-1.36% | Revisions=+40% | GrowthEPS=+11.1% | GrowthRev=+16.6%
EPS next Year (2027-12-31): EPS=1.20 | Chg30d=-0.36% | Revisions=+40% | GrowthEPS=+17.8% | GrowthRev=+17.8%
[Analyst] Revisions Ratio: +22% (up=4, down=2)